Cozzi Giorgio, Norbedo Stefania, Barbi Egidio
Emergency Department, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", via dell'Istria 65/1, 34132, Trieste, Italy.
Paediatr Drugs. 2017 Apr;19(2):107-111. doi: 10.1007/s40272-017-0217-5.
Sedation is often required for children undergoing diagnostic procedures. Chloral hydrate has been one of the sedative drugs most used in children over the last 3 decades, with supporting evidence for its efficacy and safety. Recently, chloral hydrate was banned in Italy and France, in consideration of evidence of its carcinogenicity and genotoxicity. Dexmedetomidine is a sedative with unique properties that has been increasingly used for procedural sedation in children. Several studies demonstrated its efficacy and safety for sedation in non-painful diagnostic procedures. Dexmedetomidine's impact on respiratory drive and airway patency and tone is much less when compared to the majority of other sedative agents. Administration via the intranasal route allows satisfactory procedural success rates. Studies that specifically compared intranasal dexmedetomidine and chloral hydrate for children undergoing non-painful procedures showed that dexmedetomidine was as effective as and safer than chloral hydrate. For these reasons, we suggest that intranasal dexmedetomidine could be a suitable alternative to chloral hydrate.
接受诊断性检查的儿童通常需要镇静。在过去三十年里,水合氯醛一直是儿童最常用的镇静药物之一,有证据支持其有效性和安全性。最近,考虑到其致癌性和遗传毒性的证据,意大利和法国已禁用了水合氯醛。右美托咪定是一种具有独特特性的镇静剂,越来越多地用于儿童的程序性镇静。多项研究证明了其在非疼痛性诊断检查中镇静的有效性和安全性。与大多数其他镇静剂相比,右美托咪定对呼吸驱动以及气道通畅性和张力的影响要小得多。经鼻给药可获得令人满意的检查成功率。专门比较接受非疼痛性检查的儿童使用鼻内右美托咪定和水合氯醛情况的研究表明,右美托咪定与水合氯醛一样有效且更安全。基于这些原因,我们建议鼻内右美托咪定可能是水合氯醛的合适替代品。